GEN Exclusives

More »

GEN News Highlights

Back to Item »

Tolerx and GSK Suspend Second Phase III Diabetes Trial as Defend-1 Otelixizumab Study Fails

GSK will look at potential for this humanized mAb in other autoimmune disease indications.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Lab-Grown Vaginas

Which body part do you think will be successfully engineered in the lab next?